SCHEDULE: Dauntless Investment Group Discloses Minimal Kazia Stake
Beneficial Ownership Statement
Dauntless Investment Group, LLC filed an amended Schedule 13G, reporting a 0.0% passive ownership stake in Kazia Therapeutics LTD.
Summary
- Dauntless Investment Group, LLC filed an Amendment No. 3 to Schedule 13G regarding its beneficial ownership of American Depository Shares of KAZIA THERAPEUTICS LTD.
- The reporting person, Dauntless Investment Group, LLC, is organized in Delaware and identifies as a Single Family Office/Passive Investor.
- As of the event date, Dauntless Investment Group, LLC beneficially owns 1 American Depository Share, representing 0.0% of the class.
- The reporting person holds sole dispositive power over 1 share and no sole or shared voting power.
- The filing certifies that the securities were not acquired and are not held for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine regulatory disclosure with no material impact on the company's operations or valuation due to the negligible ownership reported.
Future Outlook
No forward-looking statements or guidance are provided in this beneficial ownership filing.
Management Comments
- Dauntless Investment Group, LLC certified that, to the best of its knowledge and belief, the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 240.14a-11.
Industry Context
StockSavvy.ai notes that this is a routine regulatory disclosure for a passive investor. A 0.0% ownership stake by a single family office typically has no material impact on the company's operations, strategic direction, or its standing within the biotechnology or pharmaceutical industry.
Stakeholder Impact
- Shareholders: Minimal to no impact due to the negligible ownership stake and passive investment intent.
Key Dates
| Date | Description |
|---|---|
| 12/31/2025 | Date of event which requires filing of this statement |
| 02/12/2026 | Signature date of the filing |
Keywords
KAZIA THERAPEUTICS LTD, American Depository Shares, Schedule 13G, Beneficial Ownership, Dauntless Investment Group, Passive Investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.